Stromal cell-derived factor-encapsulated nanoparticles target ischemic myocardium and attenuate myocardial injury via proangiogenic effects.
Yajima S, Lee SH, Yang J, Vergel MD, Manna MK, Kusadokoro S, Zhu Y, Elde S, Mullis DM, Venkatesh A, Ethiraj S, Ueyama T, Takashima H, Oh SE, Huynh C, Wang H, Shudo Y, Miyagawa S, Sawa Y, Rajadas J, Woo YJ.
Yajima S, et al. Among authors: ethiraj s.
Biomaterials. 2025 Jul;318:123167. doi: 10.1016/j.biomaterials.2025.123167. Epub 2025 Feb 4.
Biomaterials. 2025.
PMID: 39947060
Free article.